Publications by authors named "Michael D Basso"

Claim this Profile
C
Clinical and Proteomic Correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in Human Heart Failure.
Julio A Chirinos, Jordana B Cohen, Lei Zhao, Thomas Hanff, Nancy Sweitzer, Michael D Basso

Hypertension· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and structure activity relationships of 7-benzyl triazolopyridines as stable, selective, and reversible inhibitors of myeloperoxidase.
Scott A Shaw, Benjamin P Vokits, Andrew K Dilger, Andrew Viet, Charles G Clark, Michael D Basso

Bioorg Med Chem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone.
Jordana B Cohen, Sarah J Schrauben, Lei Zhao, Michael D Basso, Mary Ellen Cvijic

JACC Heart Fail· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction.
Julio A Chirinos, Alena Orlenko, Lei Zhao, Michael D Basso, Mary Ellen Cvijic

J Am Coll Cardiol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PK/PD Disconnect Observed with a Reversible Endothelial Lipase Inhibitor.
Jon J Hangeland, Lynn M Abell, Leonard P Adam, Ji Jiang, Todd J Friends, Michael D Basso

ACS Med Chem Lett· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of phenylsulfone-substituted quinoxaline (WYE-672) as a tissue selective liver X-receptor (LXR) agonist.
Baihua Hu, Rayomand J Unwalla, Igor Goljer, James W Jetter, Elaine M Quinet, Michael D Basso

J Med Chem· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse.
Elaine M Quinet, Michael D Basso, Anita R Halpern, David W Yates, Robert J Steffan

J Lipid Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
Elizabeth A DiBlasio-Smith, Maya Arai, Elaine M Quinet, Mark J Evans, Tad Kornaga, Michael D Basso

J Transl Med· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in apo E-deficient mice.
M Merle Elloso, Neal Azrolan, Suren N Sehgal, Pa-Lang Hsu, Kristen L Phiel, Michael D Basso

Am J Transplant· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis